A detailed history of Re Dickinson Investment Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Re Dickinson Investment Advisors, LLC holds 664 shares of ABT stock, worth $75,848. This represents 0.04% of its overall portfolio holdings.

Number of Shares
664
Previous 664 -0.0%
Holding current value
$75,848
Previous $68,000 10.29%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$100.73 - $112.44 $2,820 - $3,148
-28 Reduced 4.05%
664 $68,000
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $80,321 - $89,495
-797 Reduced 53.53%
692 $75,000
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $67,027 - $78,894
692 Added 86.83%
1,489 $81,000
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $92,077 - $112,743
797 New
797 $112,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Re Dickinson Investment Advisors, LLC Portfolio

Follow Re Dickinson Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Re Dickinson Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Re Dickinson Investment Advisors, LLC with notifications on news.